<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Januar 2024]]></title><description><![CDATA[<p dir="auto">ALK overtager amerikanske selskab bag<br />
hudtest <a href="https://www.proinvestor.com/investornyt/1099119/alk-overtager-amerikanske-selskab-bag-hudtest" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1099119/alk-overtager-amerikanske-selskab-bag-hudtest</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400882/pharma-januar-2024</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 07:07:57 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400882.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 04 Jan 2024 17:00:04 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Januar 2024 on Wed, 31 Jan 2024 06:33:37 GMT]]></title><description><![CDATA[<p dir="auto">Novartis forward PE 24 ( EPS $4,13 + guidance high single digit ( 8% ), kurs 92,59 CHF )</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037986</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037986</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Wed, 31 Jan 2024 06:33:37 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Tue, 30 Jan 2024 11:21:11 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer fastholder guidance. <a href="https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/Q4-2023-PFE-Earnings-Release.pdf" rel="nofollow ugc">https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/Q4-2023-PFE-Earnings-Release.pdf</a> "Adjusted" EPS midtpunkt $ 2,15. Ved kurs 27,48 er forward PE 12,8. Sammenlign med Johnson&amp;Johnson ca. 30.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037983</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037983</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 30 Jan 2024 11:21:11 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Tue, 30 Jan 2024 05:21:36 GMT]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037985</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037985</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 30 Jan 2024 05:21:36 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Mon, 29 Jan 2024 11:19:01 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får positiv anbefaling af ekstra langtidsvirkende skizofrenimiddel <a href="https://www.proinvestor.com/investornyt/1109180/lundbeck-far-positiv-anbefaling-af-ekstra-langtidsvirkende-skizofrenimiddel" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1109180/lundbeck-far-positiv-anbefaling-af-ekstra-langtidsvirkende-skizofrenimiddel</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037987</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037987</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 29 Jan 2024 11:19:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Mon, 29 Jan 2024 08:15:49 GMT]]></title><description><![CDATA[<p dir="auto">Hvad tænker I om Corbus Pharmaceuticals, steg 250% i fredags på baggrund af denne <a href="https://www.corbuspharma.com/press-releases/detail/402/crb-701-sys6002-a-next-generation-nectin-4-targeting" rel="nofollow ugc">https://www.corbuspharma.com/press-releases/detail/402/crb-701-sys6002-a-next-generation-nectin-4-targeting</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037982</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037982</guid><dc:creator><![CDATA[HBEK]]></dc:creator><pubDate>Mon, 29 Jan 2024 08:15:49 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Sat, 27 Jan 2024 06:32:03 GMT]]></title><description><![CDATA[<p dir="auto">$ 2,25 mia i Roundup sag. Bayer er forgiftet. <a href="https://www.reuters.com/legal/bayer-ordered-pay-225-billion-latest-roundup-trial-2024-01-26/" rel="nofollow ugc">https://www.reuters.com/legal/bayer-ordered-pay-225-billion-latest-roundup-trial-2024-01-26/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037979</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037979</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Sat, 27 Jan 2024 06:32:03 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Fri, 26 Jan 2024 05:51:24 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037980</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037980</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 26 Jan 2024 05:51:24 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Thu, 25 Jan 2024 13:23:13 GMT]]></title><description><![CDATA[<p dir="auto">Video...Genmab er i vælten, især efter afvisningen af voldgiftsagen. Men hvad er udsigterne for 2024? Zealand Pharma-aktien bliver ved med at stige - hvad driver stigningen, og er det holdbart? Novo Nordisk kommer med regnskab 31. januar - det har mange investorer store forventninger til. Et andet spændende regnskab er Bavarian Nordic. Hvad skal pengene i kassen bruges til? Det har Helge Larsen et bud på. Til sidst er der nyt fra Lundbeck og ALK-Abelló. <a href="https://www.proinvestor.com/boards/118263" rel="nofollow ugc">https://www.proinvestor.com/boards/118263</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037984</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037984</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 25 Jan 2024 13:23:13 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Thu, 25 Jan 2024 11:53:43 GMT]]></title><description><![CDATA[<p dir="auto">ALK-Abelló: Europæisk registreringsansøgning for tabletvaccine accepteret til vurdering <a href="https://www.proinvestor.com/investornyt/1107851/alk-abello-europaeisk-registreringsansogning-for-tabletvaccine-accepteret-til-vurdering" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1107851/alk-abello-europaeisk-registreringsansogning-for-tabletvaccine-accepteret-til-vurdering</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037975</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037975</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 25 Jan 2024 11:53:43 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Thu, 25 Jan 2024 08:11:32 GMT]]></title><description><![CDATA[<p dir="auto">Johnson &amp; Johnson (verdens største pharma selskab) årsregnskab. Stille og rolig vækst i omsætning og overskud. Forudser det fortsætter i 2024. PE 30. Nærmest en obligation.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037977</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037977</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Thu, 25 Jan 2024 08:11:32 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Thu, 25 Jan 2024 05:44:30 GMT]]></title><description><![CDATA[<p dir="auto">Morning <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037981</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037981</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 25 Jan 2024 05:44:30 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Thu, 18 Jan 2024 14:10:00 GMT]]></title><description><![CDATA[<p dir="auto">ALK afslutter første del af fase 1-studie med peanuttablet <a href="https://www.proinvestor.com/investornyt/1104844/alk-afslutter-forste-del-af-fase-1-studie-med-peanuttablet" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1104844/alk-afslutter-forste-del-af-fase-1-studie-med-peanuttablet</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037976</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037976</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 18 Jan 2024 14:10:00 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Tue, 16 Jan 2024 05:26:51 GMT]]></title><description><![CDATA[<p dir="auto">Morning <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037974</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037974</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 16 Jan 2024 05:26:51 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Sat, 13 Jan 2024 14:08:57 GMT]]></title><description><![CDATA[<p dir="auto">7 Incredible Reasons to Buy Pfizer Stock Right Now <a href="https://www.proinvestor.com/investornyt/1103091/7-incredible-reasons-to-buy-pfizer-stock-right-now" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1103091/7-incredible-reasons-to-buy-pfizer-stock-right-now</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037978</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037978</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 13 Jan 2024 14:08:57 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2024 on Tue, 09 Jan 2024 09:14:21 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck-topchef ser gode muligheder for at bygge bro over patentudløb <a href="https://www.proinvestor.com/investornyt/1100878/lundbeck-topchef-ser-gode-muligheder-for-at-bygge-bro-over-patentudlob" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1100878/lundbeck-topchef-ser-gode-muligheder-for-at-bygge-bro-over-patentudlob</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037973</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037973</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 09 Jan 2024 09:14:21 GMT</pubDate></item></channel></rss>